Skip to main content

Search form

  • Email Newsletter
  • Podcast

Beta Cells in Diabetes

A resource for physicians established by the Endocrine Society

Main menu

  • Home
  • βCell Science
  • Case Studies
  • Expert Blog
  • Resources
  • CME
  • Podcasts
  • About Us

You are here

Home » Expert Blog » Blog post

Expert Blog

Podcast: A Discussion About 2012 ADA/EASD Position Statement

Posted August 2, 2012 by Doron Schneider, MD, FACP
Tags: 
weight
thiazolidinediones (TZDs)
sulfonylureas (SUs)
prediabetes
metformin
lifestyle changes
insulin therapy
glycemic control
GLP-1 agonists
DPP-4 inhibitors
beta cell pathophysiology
Doron Schneider, MD, FACP
General Internist
Biography

Listen to the Podcast and/or read the transcript. 

More Posts by this Author

  • How to Assess Second-Line Diabetes Agents for Patients at Risk for Major Osteoporotic Fractures
  • Cholesterol Guidelines: Challenges & Opportunities for Primary Care
  • Sleep Apnea in Patients with Type 2 Diabetes
  • Initial Combination Therapy in a Newly Diagnosed Patient
  • How the Affordable Care Act is Changing the Landscape of Diabetes

Related Content

  • Podcast

    Beta Cell Pathophysiology and Pharmacotherapy
  • Expert Blog

    Can Current Drug Therapy Prevent Beta Cell Failure and Bring Treatment Durability in T2DM?
  • Case Study

    Basal Insulin Fails in T2DM Patient
  • Expert Blog

    Who is the Right Patient for SGLT-2 Inhibitors?
  • Expert Blog

    How Do The ACCORD and UKPDS Trials Affect Your T2DM Patients?

Footer menu

  • RSS Feeds
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Home

BetaCellsInDiabetes.org is a resource for physicians and healthcare professionals.
The information found here is not a substitute for medical advice, diagnosis or treatment.

Endocrine Society